WADA 2026: Testing Still Rises, But Growth Has Learned to Fear

A beautiful number and a suspicious curve

297,965. That is the total number of samples the World Anti-Doping Agency (WADA) reported for 2026, in a document labeled the 2026 Annual Report. Set beside the 288,865 samples of 2026, the difference is 9,100 samples — a positive increment, a signal the organizers have every right to be proud of. But when I re-drew the curve from 2026, the picture changed color. From 2026 to 2026, testing volume rose 12.5%. From 2026 to 2026, growth was only 3.2%. Same instrument, same data set, but momentum fell by nearly four times.

I have always trusted rate of change more than absolute numbers. In eight years of swimming, I learned that one athlete can outswim another over the first 50 meters, then die in the last 100 — and the scoreboard only records total time, not rhythm. The WADA report is the same. It records totals; I want to read the rhythm. And the rhythm is slowing.

Context: this is not a swimming story

Let me be clear from the start: this is not a report about a lane in a pool. The WADA document is cross-sport anti-doping governance — swimming, track and field, football, weightlifting all sit in the same frame. No athlete names, no event content, no technical movement is mentioned. Therefore every inference about swimming technique — turns, starts, stroke efficiency — falls into the category of insufficient information, cannot assess. I will not invent a technical conclusion from a document that contains no technical data.

But there is another technical layer worth reading: sampling technology and process. That is how evidence is collected, not how athletes move through water. For an analyst, this is where the data truly lives.

The report shows WADA operating on a clearly defined regulatory cycle. The 2027 World Anti-Doping Code was adopted in Busan, South Korea, and takes effect on January 1, 2027. This is a milestone with a specific date — something every federation, including national swimming federations, can plan around. Before that, WADA and the Athlete Council ran an Athlete-Centered Consultation with more than 600 athletes and commissions from over 60 countries and more than 70 sports.

What I noticed about the 600 figure is breadth, not depth. Breadth means the rule-making process opened its doors to those directly affected. But the report does not say whether athlete input actually changed the substance of the Code. This is the familiar blind spot of every governance document: they measure participation, not influence.

The evidence chain: the heart of the matter

Numbers speak, but no one asks how many times they have wept. Let us dissect three axes.

Axis one: volume. 288,865 samples in 2026, 297,965 in 2026. This is a continuous series from 2026 to 2026, long enough that it cannot be called noise. The trend is positive. But as noted, acceleration is falling. Operationally, a decelerating curve usually means one of two things: the organization has hit a capacity ceiling, or it is deliberately shifting resources elsewhere. Neither is an absolute bad sign, but both deserve scrutiny.

Axis two, and this is the part I consider most valuable: the Adverse Analytical Finding (AAF) rate — the formal term for a positive test. Three recent years: 0.77%, 0.80%, 0.78%. The fluctuation band is only ±0.03 percentage points. This is the most robust finding in the entire report: the detection rate is standing still, almost perfectly, at roughly 0.78%. At current confidence, I treat this as a real baseline, not a ripple. In a universe full of noise, a number that holds steady for three years is a gift.

Axis three: compliance. This is where the data becomes uncomfortable. Compliance audits show average non-conformities falling from 25.5 to 20 — which sounds like good news. But the sample contains only nine audits. Nine. With n=9, that improvement is statistically fragile and may not represent the whole system. Worse, the testing non-conformity group accounts for 45% of all findings, up 11% year on year, with 23% classified as critical. In other words: the aggregate score looks better, but the most important axis — the sampling process — is getting worse.

And there is a temporal paradox worth flagging. A 2026 annual report summarizes testing figures for 2026 and 2026. The most reasonable reading: the report publishes 2026 activity with a one-year lag. If anyone cites these numbers as 2026 data, they are off by a year. I once made a similar mistake when analyzing SEA Games data, so I understand: one wrong date label is an entire wrong conclusion.

Finance is even blunter. WADA recorded an $8.3 million shortfall against budget. Of that, the United States has not paid $3.8 million and Russia owes $3.9 million. Offsetting this, the agency still ran a $1.2 million net surplus. But read those two numbers together: a surplus while revenue is short means spending was squeezed or disbursement deferred. For an organization whose main output is testing capacity, cost savings usually means shrinking capacity.

The contrarian angle: more testing does not mean cleaner or dirtier

This is where I must go against the crowd reading the news. The headline WADA increases sample testing creates the impression of a machine accelerating. The data says the opposite: the machine is decelerating. And the real question is not whether WADA tests more or less, but whether it is testing the right people.

An AAF rate frozen at 0.78% despite rising volume can mean two entirely different things. Meaning one: the true doping rate in sport is stable, and adding samples only covers a population with the same positivity. Meaning two: target selection has gotten smarter — not blanket testing but intelligence-led testing, keeping the hit rate stable. The report's data does not let me separate these. At current confidence, I will only say: the baseline is stable, and the cause is open.

Another contrarian point lies in the strategic direction itself. The report notes WADA is shifting from predominantly traditional testing to investigations and prevention. The numbers behind that sentence: more than 250 investigation operations, more than 88 laboratories dismantled, more than 90 tons seized. Read closely, this is not an organization doing more testing. It is an organization changing weapons — from individual sampling to network takedowns.

And this is where finance meets strategy. If major contributors keep paying late, WADA tends to prioritize high-yield investigations over broad testing. That, in turn, may reduce testing frequency in lower-risk sports — precisely the risk swimming must watch, because smaller swimming federations often depend on national agency resources.

In eight years of swimming, I know the feeling of being left behind. You train, you show up, you memorize your own numbers, and then you realize no one has tested you in months. That emptiness is not recorded in any report. An empty stadium is a strange marriage of data and loneliness. The WADA 2026 report is one such hall: full of numbers, empty of names.

Takeaway: signals to track

At current confidence, I set three markers for the coming cycle.

First, January 1, 2027. That is the effective date of the new Code — a fixed, plannable deadline. The compliance gap between now and then is why I advise federations to watch national agencies' early-adoption behavior.

Second, the AAF rate. If the next series breaks above 0.85%, that signals a change in true prevalence or target selection. If it keeps hugging 0.78%, this baseline still holds.

Third, the growth rate of testing volume. If next-period growth stalls or turns negative, the data will tell a story of eroding capacity — not of a cleaner sport.

On the day Germany collapsed at the 2026 World Cup, I spent three weeks gathering data and learned one thing: probability never walks alongside belief. The WADA 2026 report is the same. It does not say anti-doping wins or anti-doping loses. It says a system is growing but slowing, controlling but underfunded, changing strategy but unsure it has the resources to execute.

Numbers speak, but no one asks how many times they have wept. And in that empty hall, the question I keep for myself is not whether WADA tests more. It is: if budgets keep cracking, how many athletes in small federations will still be tested on time — and does any number record the loneliness of those never named?